Literature DB >> 8482288

Non-specific elevation of immunoreactive trypsinogen in sick infants.

D Ravine1, R I Francis, D M Danks.   

Abstract

To determine the effect of neonatal illness on immunoreactive trypsinogen (IRT) levels, the IRT values obtained in sick infants transferred to a neonatal intensive care ward were compared with those found in matched controls. IRT levels from dried blood spots collected on day 4-5 of life from 372 sick infants had a mean value of 0.095 log transformed multiples of the median, whilst controls had a mean of -0.013: a highly significant difference. Classification of the sick infants into principal diagnostic categories failed to show any group contributing disproportionately to the observation. In particular, the level of elevation observed in 33 infants with gut abnormalities such as bowel obstruction, duodenal atresia, exomphalos and gastroschisis, in which some degree of pancreatic obstruction might be expected, was not greater than in other hospitalised infants. These data show that sick infants are at increased risk of being identified by an IRT screening programme aimed at detecting infants with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482288     DOI: 10.1007/bf01956751

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Screening for cystic fibrosis: use of delta F508 mutation.

Authors:  F G Bowling; J J McGill; R W Shepherd; D M Danks
Journal:  Lancet       Date:  1990-04-14       Impact factor: 79.321

2.  Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.

Authors:  M J Rock; E H Mischler; P M Farrell; W T Bruns; D J Hassemer; R H Laessig
Journal:  Pediatr Pulmonol       Date:  1989

3.  Diagnosis of cystic fibrosis in premature infants.

Authors:  A King; R F Mueller; A F Heeley; N R Robertson
Journal:  Pediatr Res       Date:  1986-06       Impact factor: 3.756

4.  Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique.

Authors:  F G Bowling; A R Brown
Journal:  Clin Chim Acta       Date:  1988-02-15       Impact factor: 3.786

5.  An evaluation of screening for cystic fibrosis.

Authors:  B Wilcken
Journal:  Prog Clin Biol Res       Date:  1987

6.  Dried-blood spot screening for cystic fibrosis in the newborn.

Authors:  J R Crossley; R B Elliott; P A Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

7.  Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test.

Authors:  H C Ryley; S M Deam; J Williams; M Alfaham; P H Weller; M C Goodchild; R A Carter; D Bradley; J A Dodge
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

  7 in total
  4 in total

1.  Immunoreactive trypsin levels in neonates with meconium ileus.

Authors:  L C Steven; G Gavel; D Young; R Carachi
Journal:  Pediatr Surg Int       Date:  2006-01-03       Impact factor: 1.827

2.  False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin?

Authors:  D Cheillan; M Vercherat; F Chevalier-Porst; M Charcosset; M O Rolland; C Dorche
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  The impact of newborn screening on cystic fibrosis testing in Victoria, Australia.

Authors:  M E Balnaves; L Bonacquisto; I Francis; J Glazner; S Forrest
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

4.  Differences in immunoreactive trypsin values between type of feeding and ethnicity in neonatal cystic fibrosis screening: a cross-sectional study.

Authors:  Ernesto Cortés; Ana María Roldán; Antonio Palazón-Bru; María Mercedes Rizo-Baeza; Herminia Manero; Vicente Francisco Gil-Guillén
Journal:  Orphanet J Rare Dis       Date:  2014-11-07       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.